Mologic is an SME (small and medium enterprise). As we have fewer than 50 employees, we are officially a “small” enterprise according to the EU definition.

We actively pursue exciting collaborative research opportunities, so please contact us if you need a dynamic, UK-based SME for your research consortium.

Mologic left Alere Inc (after 5 productive years), following a management buy-out (MBO) at the end of December 2014. It has returned to the stewardship of CEO Mark Davis and CSO Prof Paul Davis – its original founders.

Mologic is a leading developer of lateral flow and rapid diagnostic technologies, products and services. We work with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care.

Our Co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test. Launched in 1988, it was the world’s first commercial application of lateral flow technology. The creativity, insight and knowledge that led to that ground-breaking invention has guided Mologic since our formation in 2003.